Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Alterity Therapeutics ( (AU:ATH) ) has provided an announcement.
Alterity Therapeutics has called a virtual General Meeting of shareholders to be held on 29 May 2026 at 12:00pm AEST via the Automic online platform. The notice of meeting and explanatory materials are available on the company’s website and ASX announcements page, with eligibility to vote determined by shareholdings as at 7:00pm AEST on 27 May 2026.
The company is encouraging investors to participate by lodging directed proxy votes online ahead of the meeting and by submitting questions in advance to allow management to prepare responses. Shareholders will still be able to vote and ask questions during the live online event, and the board has flagged that any changes to meeting arrangements will be communicated via ASX and the company’s website.
The most recent analyst rating on (AU:ATH) stock is a Buy with a A$0.01 price target. To see the full list of analyst forecasts on Alterity Therapeutics stock, see the AU:ATH Stock Forecast page.
More about Alterity Therapeutics
Alterity Therapeutics Limited is an Australian biotechnology company listed on the ASX under the code ATH. The company focuses on developing therapeutics in the life sciences sector, targeting neurological and related disorders for a global healthcare market.
Average Trading Volume: 7,823,400
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$108.8M
Find detailed analytics on ATH stock on TipRanks’ Stock Analysis page.